)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Lipocine (LPCN) investor relations material
Lipocine Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Focus on oral drug delivery for CNS disorders, liver diseases, hormone supplementation, postpartum depression, epilepsy, and obesity management, with a pipeline including LPCN 1154, LPCN 2401, LPCN 2101, and LPCN 2203.
Commercialization of TLANDO (oral testosterone therapy) through licensing agreements in the US, Canada, South Korea, GCC, and Brazil, with milestone and royalty payments.
Ongoing Phase 3 trial for LPCN 1154 in postpartum depression, with top-line data expected in Q2 2026 and NDA submission planned for 2026.
Exploring proof-of-concept studies for epilepsy (LPCN 2101) and obesity (LPCN 2401), with partnership discussions ongoing.
Financial highlights
Total revenue for Q3 2025 was $115,000, all from royalty revenue; no license revenue recognized in the quarter.
Net loss for Q3 2025 was $3.2 million ($0.59 per share), compared to $2.2 million ($0.44 per share) in Q3 2024.
For the nine months ended September 30, 2025, revenue was $831,000 (license: $500,000; royalty: $331,000), down from $7.7 million in the prior year period.
Research and development expenses increased to $2.7 million in Q3 2025, mainly due to the LPCN 1154 Phase 3 trial.
Cash, cash equivalents, and marketable investment securities totaled $15.1 million as of September 30, 2025.
Outlook and guidance
Existing capital resources are expected to fund operations through at least November 6, 2026, including ongoing clinical studies.
Top-line data from the LPCN 1154 Phase 3 trial expected in Q2 2026; NDA submission planned for 2026.
Additional capital will be needed for further development, regulatory compliance, and potential new clinical trials.
The company is actively seeking partnerships and licensing opportunities for pipeline assets.
LPCN 1154 partnering strategy and timeline?
Project cash runway with current R&D commitments?
TLANDO royalty revenue growth expectations for 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Lipocine earnings date
Q4 202510 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Lipocine Inc. is a biopharmaceutical company focused on the development of oral drug delivery technologies for treating metabolic and endocrine disorders. The company specializes in hormone therapeutics, leveraging its proprietary Liprocol technology to enhance drug absorption and bioavailability. Lipocine's pipeline includes treatments for conditions such as testosterone deficiency, liver disease, and neuroendocrine disorders. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage